Robert W. Baird analyst Eric Coldwell reiterated a Buy rating on AdaptHealth (NASDAQ:AHCO) on Friday, setting a price target of $49, which is approximately 32.47% above the present share price of $36.99.
Coldwell expects AdaptHealth to post earnings per share (EPS) of -$0.47 for the second quarter of 2021.
The current consensus among 5 TipRanks analysts is for a Strong Buy rating of shares in AdaptHealth, with an average price target of $48.6.
The analysts price targets range from a high of $50 to a low of $46.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $348.43 million and a net profit of $32.31 million. The company's market cap is $4.25 billion.
According to TipRanks.com, Robert W. Baird analyst Eric Coldwell is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 13.2% and a 64.47% success rate.
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.